irAE(immune-related adverse event)
Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study 【雑誌】J Immunother Cancer. 2021 Nov;9(11):e003277. doi: 10.1136/jitc-2021-0032…
Immune-related adverse events are clustered into distinct subtypes by T-cell profiling before and early after anti-PD-1 treatment. 【雑誌】 Oncoimmunology. 2020 Feb 2;9(1):1722023. https://www.tandfonline.com/doi/full/10.1080/2162402X.2020…
